Clinical Laserthermia Systems Introduces MRI-Guided Laser Ablation System for Minimally-Invasive Treatment of Soft Tissue
Framingham, MA – April 9, 2018 - Clinical Laserthermia Systems Americas, Inc. (CLS) a subsidiary of CLS AB in Lund, Sweden, today announced the availability of its TRANBERG® Thermal Therapy System, including a mobile laser system and single-use products, for high precision, image guided, laser ablation of soft tissue. This advanced focal therapy provided by the TRANBERG System is designed to reduce morbidity and improve clinical outcomes within interventional oncology and urology. The system is currently in use at numerous hospitals in the U.S., Sweden, and other European countries.
U.S. customers for CLS include the University of Texas Medical Branch, the Laser Prostate Centers of America, and Desert Medical Imaging. CLS received FDA-clearance for its single-use TRANBERG®|Laser Applicator Non-cooled diffusor fiber in early 2017.
“We are very pleased by the enthusiastic feedback given to us on the use of our products and the positive patient results being reported by our prominent partners and physicians,” said Dan Mogren, CCO of CLS. “We are now beginning to see new and larger orders as well as repeat orders coming from the market, which is an important sign of acceptance.
High Precision Thermal Therapy System
The TRANBERG® |Thermal Therapy System has been developed for image guided high precision soft tissue thermal therapy and ablation procedures. The system can be configured for MR or CT/US guided procedures using tissue temperature feedback for precise therapy and ablation control. It includes a desk-top mobile laser unit, new innovative non-cooled laser applicators, external tissue temperature probe sensors, and procedure specific accessories.
Laser Applicator Non-cooled
The applicator portfolio includes 3m and 12m non-cooled 16 Gauge laser applicators allowing for almost any type of image guidance, including MR. With CLS’ unique diffusing fiber technology, heat distribution in tissue is optimized and the need for external cooling is eliminated. Features also aimed at improving workflow and shortening procedure time.
Tissue Temp Probe
For high precision during CT/US guided procedures, high accuracy temperature probes can be used for monitoring and controlling tissue temperatures in and around the target tissue.
About Clinical Laserthermia Systems
Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System including its specially-designed sterile disposable products for safe, gentle and effective treatment of soft tissue such as cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and has a subsidiary in Boston, MA, is listed on Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on www.clinicallaser.se.
The TRANBERG®|Thermal Therapy System has not yet received market clearance for immune stimulating interstitial laser thermotherapy (imILT®) by the Food and Drug Administration (FDA) in the United States of America (USA).
CLS Americas, Inc.
Alan Weinberg, General Manager
P: (508) 620-4521
Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se